CytoDyn Inc. | Business Contracts

Amended and Restated 2012 Equity Incentive Plan (Filed With SEC on January 9, 2023)

Form Stock Option Award Agreement (For Executives) (Filed With SEC on January 9, 2023)

Second Amendment dated December 1, 2022, to Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (Filed With SEC on December 7, 2022)

Settlement Agreement dated May 19, 2022, between CytoDyn Inc. and Richard G. Pestell, M.D., Ph.D (Filed With SEC on August 15, 2022)

Commercialization and License Agreement between CytoDyn Inc. and Vyera Pharmaceuticals, LLC, dated December 17, 2019 (Filed With SEC on January 9, 2020)

Form Stock Option Award Agreement (For Non-Employee Directors) (Filed With SEC on January 9, 2023)

Description of the Registrants Capital Stock (Filed With SEC on August 15, 2022)

Employment Agreement between CytoDyn Inc. and Cyrus Arman, effective July 9, 2022 (Filed With SEC on August 15, 2022)

CERTAIN IDENTIFIED INFORMATION MARKED BY [*] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT... (Filed With SEC on August 15, 2022)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Biomm S.A., dated April 6, 2021 (Filed With SEC on August 15, 2022)

Warrant Issued to Richard G. Pestell (Filed With SEC on August 15, 2022)

Amendment dated July 18, 2022, to Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (Filed With SEC on July 25, 2022)

Separation Agreement and Release of Claims Claims with Nader Z. Pourhassan, Ph.D., effective March 8, 2022 (Filed With SEC on April 11, 2022)

Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (Filed With SEC on April 11, 2022)

Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (the Company agrees to furnish a copy of Schedule 3, which has been... (Filed With SEC on February 17, 2022)

Form of Make-Whole Warrant (Filed With SEC on February 17, 2022)

Form of Initial Warrant (Filed With SEC on February 17, 2022)

Form of Subscription Agreement (Filed With SEC on November 23, 2021)

Employment Agreement by and between CytoDyn Inc. and Antonio Migliarese, effective May 18, 2021 (Filed With SEC on October 12, 2021)

Form of Warrant Exercise Inducement Agreement (Filed With SEC on September 7, 2021)

Form of Subscription Agreement (Filed With SEC on September 7, 2021)

Form of Warrant (Filed With SEC on September 7, 2021)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Chiral Pharma Corporation (Filed With SEC on July 30, 2021)

Description of the Registrants Capital Stock (Filed With SEC on July 30, 2021)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Biomm S.A., dated April 6, 2021 (Filed With SEC on July 30, 2021)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Chiral Pharma Corporation, as amended by Amendment No. 1, dated April 19, 2021 (Filed With SEC on July 30, 2021)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Macleods Pharmaceuticals Ltd., dated May 11, 2021 (Filed With SEC on July 30, 2021)

Separation Agreement and Release of Claims between CytoDyn Inc. and Mahboob U. Rahman, M.D., Ph.D., dated June 1, 2021 (Filed With SEC on July 30, 2021)

Security Agreement between CytoDyn Inc. and Uptown Capital, LLC dated April 23, 2021 (Filed With SEC on April 29, 2021)

Securities Purchase Agreement between CytoDyn Inc. and Uptown Capital, LLC dated April 23, 2021 (Filed With SEC on April 29, 2021)

Secured Convertible Promissory Note dated April 23, 2021 (Filed With SEC on April 29, 2021)

Employment Agreement by and between CytoDyn Inc. and Christopher P. Recknor, M.D., dated March 11, 2021 (Filed With SEC on April 14, 2021)

Secured Convertible Promissory Note dated April 2, 2021 (Filed With SEC on April 8, 2021)

Security Agreement between CytoDyn Inc. and Streeterville Capital LLC dated April 2, 2021 (Filed With SEC on April 8, 2021)

Securities Purchase Agreement between CytoDyn Inc. and Streeterville Capital LLC dated April 2, 2021 (Filed With SEC on April 8, 2021)

Form of Warrant Exercise Inducement Agreement (Filed With SEC on January 29, 2021)

Employment Agreement by and between CytoDyn Inc. and Mahboob Rahman M.D., Ph.D., dated October 16, 2020 (Filed With SEC on January 8, 2021)

Secured Convertible Promissory Note dated November 10, 2020 (Filed With SEC on November 16, 2020)

Securities Purchase Agreement between CytoDyn Inc. and Streeterville Capital, LLC dated November 10, 2020 (Filed With SEC on November 16, 2020)

Security Agreement between CytoDyn Inc. and Streeterville Capital, LLC dated November 10, 2020 (Filed With SEC on November 16, 2020)

Distribution and Supply Agreement between CytoDyn Inc. and American Regent, Inc. dated July 2, 2020 (Filed With SEC on August 18, 2020)

General Release and Separation Agreement between CytoDyn Inc. and Craig S. Eastwood, dated April 24, 2020 (Filed With SEC on August 14, 2020)

CytoDyn Inc. Amended and Restated 2012 Equity Incentive Plan (the 2012 Plan) (Filed With SEC on August 14, 2020)

Form of Stock Option Award Agreement for Executive Employees under the 2012 Plan (Filed With SEC on August 14, 2020)

Amended and Restated Employment Agreement by and between CytoDyn Inc. and Nitya G. Ray, Ph.D., dated June 15, 2020 (Filed With SEC on August 14, 2020)

Description of the Registrants Capital Stock (Filed With SEC on August 14, 2020)

Employment Agreement by and between CytoDyn Inc. and Arian Colachis, dated March 16, 2020 (Filed With SEC on August 14, 2020)

Employment Agreement by and between CytoDyn Inc. and Scott A. Kelly, M.D., dated April 10, 2020 (Filed With SEC on August 14, 2020)

Distribution and Supply Agreement between CytoDyn Inc. and American Regent, Inc (Filed With SEC on August 14, 2020)

Security Agreement between CytoDyn Inc. and Iliad Research and Trading, L.P. dated July 29, 2020 (Filed With SEC on July 31, 2020)

Securities Purchase Agreement between CytoDyn Inc. and Iliad Research and Trading, L.P. dated July 29, 2020 (Filed With SEC on July 31, 2020)

Secured Convertible Promissory Note dated July 29, 2020 (Filed With SEC on July 31, 2020)

Second Amended and Restated Employment Agreement of CEO Nader Z. Pourhassan Ph.D (Filed With SEC on June 19, 2020)

Amended and Restated Employment Agreement CFO Michael D. Mulholland (Filed With SEC on June 19, 2020)

Amendment No. 5 to the 2012 Equity Incentive (Filed With SEC on June 19, 2020)

Form of Stock Option Agreement for Employees (Filed With SEC on June 19, 2020)

Form of Performance Stock Unit Agreement (Filed With SEC on June 19, 2020)

Form of Restricted Stock Unit Agreement (Filed With SEC on June 19, 2020)

Form of Performance Share Award Agreement (Filed With SEC on April 9, 2020)

Secured Convertible Promissory Note, as amended (Filed With SEC on April 6, 2020)

Security Agreement (Filed With SEC on April 6, 2020)

Securities Purchase Agreement (Filed With SEC on April 6, 2020)

Form of Series D Warrant Agreement (Filed With SEC on February 3, 2020)

Form of Subscription Agreement (Filed With SEC on February 3, 2020)

Form of Amendment to Executive Officer Employment Agreements (Filed With SEC on January 9, 2020)

Employment Agreement by and between CytoDyn Inc. and Maura Fleming, dated January 6, 2020 (Filed With SEC on January 9, 2020)

Employment Agreement by and between CytoDyn Inc. and Craig S. Eastwood, dated December 6, 2019 (Filed With SEC on January 9, 2020)

Supply Agreement between CytoDyn Inc. and Vyera Pharmaceuticals, LLC, dated December 17, 2019 (Filed With SEC on January 9, 2020)

Form of Warrant Exercise Agreement (Filed With SEC on December 27, 2019)

Form of Subscription Agreement (Filed With SEC on December 27, 2019)

Form of Warrant Agreement (Filed With SEC on December 27, 2019)

Form of Subscription Agreement (Filed With SEC on November 7, 2019)

Form of Subscription Agreement (Filed With SEC on October 22, 2019)

Form of Series C Warrant Agreement (Filed With SEC on October 22, 2019)

Form of Subscription Agreement (Filed With SEC on October 3, 2019)

Form of Subscription Agreement (Filed With SEC on September 19, 2019)

Placement Agent Agreement (Filed With SEC on August 29, 2019)

Form of Series C Subscription Agreement (Filed With SEC on August 29, 2019)

Form of Registered Direct Subscription Agreement (Filed With SEC on August 29, 2019)

Form of Registered Direct Warrant Agreement (Filed With SEC on August 29, 2019)

Product Specific Agreement between CytoDyn Inc. and Samsung BioLogics Co., Ltd, dated April 1, 2019 (Filed With SEC on August 14, 2019)

Master Services Agreement between CytoDyn Inc. and Samsung BioLogics Co., Ltd, dated April 1, 2019 (Filed With SEC on August 14, 2019)

Description of the Registrants Capital Stock (Filed With SEC on August 14, 2019)

Consulting Agreement, dated July 15, 2019, between CytoDyn Inc. and David F. Welch, Ph.D (Filed With SEC on July 19, 2019)

Consulting Agreement, dated July 15, 2019, between CytoDyn Inc. and Scott A. Kelly, M.D (Filed With SEC on July 19, 2019)

Form of Exercise Agreement (Filed With SEC on May 9, 2019)

Form of Subscription Agreement (Filed With SEC on April 5, 2019)

Form of Warrant Agreement (Filed With SEC on April 5, 2019)

Placement Agent Agreement (Filed With SEC on April 5, 2019)

Form of Subscription Agreement (Filed With SEC on March 20, 2019)

Form of Series C Warrant Agreement (Filed With SEC on March 20, 2019)

Placement Agent Agreement (Filed With SEC on January 31, 2019)

Form of Subscription Agreement (Filed With SEC on January 31, 2019)

Convertible Promissory Note Warrant Agreement (Filed With SEC on January 31, 2019)

Form of Warrant Agreement (Filed With SEC on January 31, 2019)

Convertible Promissory Note (Filed With SEC on January 30, 2019)

Security Agreement (Filed With SEC on January 30, 2019)

Securities Purchase Agreement (Filed With SEC on January 30, 2019)

Form of Warrant to Purchase Common Stock (Filed With SEC on January 3, 2019)

Form of Subscription Agreement (Filed With SEC on January 3, 2019)

Form of Convertible Promissory Note (Filed With SEC on January 3, 2019)

CytoDyn Inc. (103)